A
Aligos Therapeutics D
D
ALGS
8.11000
USD
-0.35
(-4.14%)
مفتوح الان
حجم التداول
1,330
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
49,591,036
الأخبار المقالات
العنوان: Aligos Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.